Reply to: "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Letter].

Published in: International journal of chronic obstructive pulmonary disease (2021)

Keyphrases